Taylor Ngo, MPH

Enanta Pharmaceuticals
Watertown, Massachusetts, United States

Disclosure information not submitted.

Presentation(s):

• 135 - Zelicapavir (EDP-938) Antiviral Treatment is Associated with Shortened Duration of RSV Symptoms in a Randomized, Double-Blind, Placebo-Controlled, Clinical Trial in Children 28 Days to 36 Months of Age

  Monday, October 20, 2025
  12:35 PM - 12:40 PM US ET